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Abstract 1 
Next-generation sequencing offers an unprecedented opportunity to jointly analyze cellular and 2 
viral transcriptional activity, without prerequisite knowledge on the nature of the transcripts. 3 
SupT1 cells were infected with a VSV-G pseudotyped HIV vector. At 24 hours post-infection, 4 
both cellular and viral transcriptomes were analyzed by Serial Analysis of Gene Expression 5 
followed by high-throughput sequencing (SAGE-Seq). Read mapping resulted in 33 to 44 million 6 
tags aligning to the human transcriptome and 0.23 to 0.25 million tags aligning to the genome of 7 
the HIV-1 vector. Thus, at peak infection, one transcript in 143 is of viral origin (0.7%), 8 
including a small component of antisense viral transcription. Out of the detected cellular 9 
transcripts, 826 (2.3%) were differentially expressed between mock and HIV-infected samples. 10 
The approach also assessed whether HIV-1 infection modulates expression of repetitive elements 11 
or endogenous retroviruses. We observed very active transcription of these elements, with one 12 
transcript in 237 being of such origin, corresponding in average to 123,123 reads in mock 13 
(0.40%) and 129,149 reads in HIV-1 (0.45%) mapping to the genomic Repbase repository. This 14 
analysis highlights key details in the generation and interpretation of high-throughput data in the 15 
setting of HIV-1 cellular infection.16 
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 17 
Introduction 18 
There is significant interest in determining the level of HIV-1 transcription in the context of the 19 
infected cell. The impact of HIV-1 infection on cellular gene expression has been investigated in 20 
the past by gene expression arrays (3, 7, 9, 10, 15-18, 20, 21, 29, 31, 36, 37, 42, 47, 48, 51). 21 
However, use of these arrays is limited by the set of probes that are included in the chip. 22 
Recently, it has even been proposed that unbiased analysis of transcription activity by deep 23 
sequencing will soon replace gene expression profiling by microarrays (6, 45, 49). The first 24 
application of the novel technologies in the field of HIV-1 has been in the assessment of viral 25 
sequence variation, in particular mutations present at low frequency in complex (quasispecies) 26 
populations (2, 8, 12, 19, 22, 23, 43, 46, 50, 52, 55). Pyrosequencing approaches have also been 27 
instrumental in the assessment of small non-coding RNAs in HIV-1 infected cells (54). The next 28 
goal is the joint analysis of the viral and host transcriptome of the infected cell.  29 
  30 
Two general methods of deep sequencing are defined on the basis of the mode of sample 31 
preparation (28). One approach uses fractionation of polyadenylated RNAs (valid also for non 32 
poly(A)+ RNAs) in short fragments, followed by reverse transcription using hexamers. Adapters 33 
are ligated to both ends, and used for sequencing. This method allows the detailed 34 
characterization of the transcript structure. A second approach uses Serial Analysis of Gene 35 
Expression (SAGE) to allow precise quantization of poly(A)+ RNA and to facilitate information 36 
on strandedness, a key for the understanding of antisense transcription of the HIV-1 genome. An 37 
important consideration regarding these technologies is the growing consensus that they will 38 
represent the new gold-standard in the analysis of transcription – deep sequencing-based 39 
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expression analysis has shown to represent a major advance in robustness, resolution and inter-40 
lab portability over multiple microarray platforms (6, 45, 49).  41 
  42 
In the present study, we used Super-SAGE, followed by high-throughput sequencing (SOLiD, 43 
Life Technologies), also known as Digital Gene Expression (DGE) tag profiling, 3’ tag DGE, tag 44 
sequencing (Tag-Seq), or SAGE-Seq (32, 33, 38, 53), to analyze the transcriptome of a T cell line 45 
24 hours post-infection.  46 
 47 
Materials and Methods 48 
Cells. HEK 293T cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, 49 
Invitrogen), supplemented with 10% heat-inactivated fetal calf serum (FCS) and 50 µg/ml 50 
gentamycin (D-10 culture medium). SupT1 cells (a T-cell line) were cultured in RPMI-1640 51 
(Invitrogen), supplemented with 10% heat-inactivated FCS and 50 µg/ml gentamycin (R-10 52 
culture medium). 53 
 54 
HIV-vector production. To produce HIV-based vector particles, 293T cells were co-transfected 55 
with two plasmids (20 µg total) using the calcium phosphate method (Invitrogen) and according 56 
to the manufacturer’s instructions. One plasmid, pNL4-3∆env-eGFP, codes for all viral proteins 57 
except the envelope, which was disrupted and replaced by GFP (56). The second plasmid, 58 
pMD.G, encodes the vesicular stomatitis virus G envelope protein (VSV-G) (39). Forty-eight 59 
hours after transfection, culture supernatant containing viral particles was collected, centrifuged 60 
to pellet cell debris, filtered through 0.22 µm filters, concentrated using Centricon-Plus 70-100K 61 
(Millipore), treated with 100 U/ml DNaseI (Roche) and stored frozen at -80°C. Virion 62 
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concentration was assessed by measuring the CA (p24) antigen by ELISA (Murex HIV Ag MAB; 63 
Abbott), according to instructions. 64 
 65 
HIV infection. SupT1 cells (5x106) were infected with 15 µg p24 equivalent of HIV NL4-66 
3∆env-eGFP/VSV-G in presence of 5 µg/ml polybrene (Sigma) by centrifugation for 30 min at 67 
1500 g. Mock cells were treated similarly but without HIV-based particles. Cells were washed 68 
with culture medium, resuspended at 106 cells/ml in R-10 and further incubated. 69 
 70 
Transcriptional profiling by SAGE-Seq and bioinformatic analysis. At 24h post-exposure, 71 
cells were washed once with phosphate-buffered saline (PBS) and resuspended in 0.5 ml 72 
RNALater (Ambion). Total RNA was purified using miRvana isolation kit (Ambion), or TRIzol 73 
(Invitrogen) for the second experiment, according to recommendations. RNA quality was 74 
assessed by electrophoresis on the Bioanalyzer 2100 (Total RNA Nano; Agilent). SAGE libraries 75 
were prepared with SOLiD SAGE kit (Applied Biosystems) at the Functional Genomics Center 76 
Zurich. High-throughput sequencing was performed using SOLiD3 technology (Applied 77 
Biosystems). Sequence mapping was done with the bowtie software (27), using defined analysis 78 
parameters (read length (rl), number of mismatches (n) and alignments authorized (m)). Tag hits 79 
(i.e. successfully aligned reads) were normalized according to the number of locations they 80 
mapped to. Alignment used the human genome GRCh37, the human transcriptome RefSeq 81 
database, and HIV-1 genome HIV NL4-3∆env-eGFP. Differential expression analysis was 82 
performed using R programming language (14) and based on negative-binomial modeling of 83 
count data as described in the Bioconductor package DESeq (1). Genes with significantly 84 
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modulated expression in HIV-1 samples compared to mock samples were selected with a false 85 
discovery rate (FDR) of 0.05 and annotation was retrieved using the biomaRt package (11). 86 
 87 
Northern hybridization. Total RNA (10 µg) from mock-treated or HIV vector-infected cells 88 
was supplemented with RNA loading buffer (Bioline), heated 5 min at 65°C and separated by 89 
electrophoresis on 1.2% agarose-MOPS-formaldehyde gel (44). The gel was washed 3x10 min 90 
with 10xSSC. RNA transfer from gel to nitrocellulose membrane (Hybond  N+; GE Healthcare) 91 
was performed over night by capillarity using 20x SSC. The membrane was rinsed with 6xSSC, 92 
crosslinked with UV (GeneLinker; BioRad), rinsed briefly with water and added to 10 ml 93 
preheated QuickHyb Hybridization solution (Agilent) for 30 min at 65°C.  200 pmol 94 
oligonucleotide probes were labeled with 20 µCi  [γ−32P]dATP with 10 U T4 polynucleotidyl 95 
kinase (T4 PNK; New England Biolabs) for 1h at 37°C. After heat inactivation of the enzyme for 96 
10 min at 95°C, probes were purified on Qiaquick Nucleotide removal kit (Qiagen), mixed with 97 
100 µl sonicated salmon sperm DNA [10 mg/ml] (Eppendorf), and added to the membrane in 98 
QuickHyb Hybridization solution for 1h at 65°C. Following hybridization, membrane was 99 
washed 2x15 min with 2xSSC/0.1% SDS at room temperature, 1x30 min in 2xSSC/0.1% SDS at 100 
52°C, exposed to an intensifying screen over night at -80°C and revealed using ImageQuantTL 101 
v2005 software on Typhoon scanner (GE Healthcare). For re-use, membrane was stripped with 102 
boiling 0.1xSSC/0.1%SDS twice for 15 min. Oligonucleotide probes were 5’- 103 
TCTCTCTCAGGGTCATCCATTCCA-3’ for peak 1 sense transcripts, 5’- 104 
GCTCGTCCTTGTACAGCTCGTCCA-3’ for peak 3 sense transcripts, 5’- 105 
ATGGTGTTTTACTAATCTTTTCCATGTGTT-3’ for peak 4 sense transcripts, 5’- 106 
CTTGTTACACCCTGTGAGCCTGCA-3’ for peak 1 antisense transcripts, 5’- 107 
8 
 
CCGCCGCCGGGATCACTCTCGGCA-3’ for peak 3 antisense transcripts and 5’- 108 
GTAGACAGGATGAGGATTAACACATGGAAA-3’ for peak 4 antisense transcripts. As 109 
positive control for hybridization, 2 µg pNL4-3∆env-eGFP digested with BglII and AflII was 110 
used. 111 
 112 
Results and Discussion 113 
SupT1 cells (5x106 cells) were mock-treated or infected with a VSV-G pseudotyped HIV-based 114 
vector expressing GFP (56) in duplicate (Figure 1A). At 36h post-infection, FACS analysis 115 
revealed that 93% of cells were successfully transduced, expressing GFP; other cell types were 116 
tested and found less efficient in transduction (Supplemental File 1A). The use of 24h time point 117 
in the experimental model takes into consideration cell loss and viability, initiation of translation, 118 
as measured by GFP expression (as soon as 16 hours), and the completion of the viral cycle, as 119 
measured by the production and release of p24 (as soon as 20 hours), reflecting viral particle 120 
release in SupT1 cells (Supplemental File 1B).  Cells were collected for total RNA extraction 121 
and poly(A)+ RNAs were reverse transcribed and processed for SAGE library preparation. 122 
cDNAs were digested with NlaIII, a frequent 4-bp cutter, and ligated to an adaptor sequence, 123 
containing the recognition site of EcoP15I; an enzyme that cuts DNA asymmetrically, 25/27bp 124 
away. A second adapter was ligated leading to a 27bp transcript-specific tag, surrounded by two 125 
distinct adapter sequences. High-throughput sequencing was performed using the SOLiD 3 126 
system with a universal primer annealing to the adaptor sequence. Reads were mapped either to 127 
the human genome (GRCh37), the human RefSeq database (40), the human repetitive-element 128 
database (24), or the HIV-1 vector genome (HIV NL4-3∆env-eGFP/VSV-G) (Figure 1B).  129 
 130 
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Assessment of sequence alignment parameters. Variation of mapping parameters for HIV-1 131 
tags was tested to maximize the number of tags mapping to the viral genome while minimizing 132 
the number of tags spuriously mapping to the host genome (Supplemental File 2). After 133 
shortening the reads by right-trimming, we used the read lengths of 21bp, 24bp, and 27bp. In 134 
addition, we tested different number of mismatches (n=0, 1, or 2) and multiple hits (m=1, 2, or 135 
10). We retained condition rl=24, n=1 and m=1 as optimal for read mapping to the human 136 
genome, rl=24, n=1 and m=10 for mapping to the human transcriptome, and rl=24, n=2 and m=2 137 
for mapping to the HIV-1 genome. 138 
 139 
 HIV-1 RNA tags identify sense and antisense transcription. Read mapping resulted in 33 to 140 
44 million tags aligning to the human transcriptome and 0.23 to 0.25 million tags aligning to the 141 
genome of the HIV-1 vector (Table 1). These data suggest that, at peak infection, one transcript 142 
in 143 is of viral origin (0.7%).  Overall, 0.33% were HIV-1-specific (1 in 309) and 0.37% were 143 
vector GFP-specific (1 in 267).     144 
  145 
The distribution of tags on the HIV-1 vector genome emphasized several relevant aspects of 146 
HIV-1 transcription (Figure 2A). Five viral genomic regions carried 87.8% of total tags detected. 147 
A high proportion of tags (24.2%) mapped to the 3’end of the HIV-1 vector genome (Figure 2A, 148 
Peak 1), corresponding to sense transcription with a known functional polyadenylation site of 149 
HIV-1 (genome positions 9455-9460), and the first upstream NlaIII restriction site (pos. 9150). 150 
The second signal (Figure 2A, Peak 2), carrying 5.1% of total tags, corresponds to sense 151 
transcription and the same known functional polyadenylation site of HIV-1 or an alternative 152 
putative signal (at pos. 9108-9113), up to the second upstream NlaIII restriction site (pos. 8757). 153 
The third signal (Figure 2A, Peak 3), with 51.6% total tags, mapped at the end of the gfp orf, 154 
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with sense transcription, ending at a putative polyadenylation signal at pos. 7133-7138, reaching 155 
an upstream NlaIII restriction site at pos. 7072. The massive presence of these gfp tags suggests 156 
that viral transcription is skewed in favor of stable gfp transcripts, rendering this vector 157 
particularly suited as a reporter of HIV infection. Nevertheless, it seems unlikely that this 158 
putative poly(A) signal (located in the env orf) is used during transcription of wild type HIV-1. 159 
Further investigation of viral transcripts using wild-type HIV-1 should confirm this. The fourth 160 
signal (Figure 2A, Peak 4), representing 4.8% of total tags, is consistent with antisense viral 161 
transcription using a polyadenylation signal at pos. 4908-4903, reported previously by Landry et 162 
al. (26) , up to a first downstream NlaIII restriction site at pos. 5099. The fifth signal (Figure 2A, 163 
Peak 5), with 2.1% of total tags, corresponds to antisense transcription ending at an unidentified 164 
polyadenylation site, and up to the first downstream NlaIII restriction site at pos. 1226. The 165 
remaining 12.2% of tags mapping elsewhere to the genome correspond mostly to the use of 166 
further NlaIII restriction sites or alternative, putative poly(A) sites.  167 
  168 
The technical procedure, from SAGE library preparation to high-throughput sequencing, keeps 169 
track of strand specificity. Sequences are read from a universal primer in the first adapter (on the 170 
poly(A) side) towards the NlaIII site. Sense tags will map 3’ from the NlaIII site, while antisense 171 
tags will map 5’ of the NlaIII site. Globally, 20.5% of tags mapped to the HIV-1 vector genome 172 
in the antisense orientation (Figure 2A). Peaks 4 and 5 are comprised mostly of antisense tags 173 
(88% and 92%, respectively); however, antisense tags were also present at the 3’ end of the viral 174 
genome (40.5% and 49.0%, for peaks 1 and 2, respectively). In contrast, a negligible amount of 175 
tags in the antisense orientation mapped to the third peak, corresponding to GPF (only 1 out of 176 
125,970 tags).  With the exception of peak four, we did not identified canonical poly(A) signals 177 
(AATAAA, ATTAAA, AGTAAA, AAGGAA) that would associate with the observed 178 
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accumulation of antisense tags. Confirming and understanding HIV-1 antisense transcription is 179 
important because of the a possible roles for such transcripts in the regulation of viral expression 180 
(54), the generation of antisense proteins (26, 30, 34, 35), or the production of cryptic epitopes 181 
(4). However, the assessment of antisense transcription and cognate poly(A) motifs is not 182 
straightforward. Specifically, Landry et al. indicated that RT-PCR cannot reliably separate sense 183 
vs anti-sense transcripts due to endogenous RT priming, and would therefore require the use of 5' 184 
LTR-deleted pNL4-3 constructs , and cloning and sequencing of the 3'RACE amplified products 185 
(26). First, we repeated a deep sequencing experiment, using barcoded adapters (initially 186 
designed for sample multiplexing) during the library preparation of SAGE-Seq, as it was 187 
suggested that barcoding samples might generate less artifacts (53). Although the overall 188 
distribution profile of the tags was comparable, only about 0.9% antisense tags were detected. To 189 
further estimate the proportion of viral antisense transcription, we performed Northern blots 190 
using specific sense and antisense probes (Figure 2B). 2-kb, 4-kb and 9-kb classes of viral sense 191 
transcripts were detected expectedly according to the specific probe used. However, none of the 192 
probes designed to anneal to antisense transcripts revealed any detectable signal. These data 193 
suggest that viral antisense transcription is more consistent with 0.9% abundance than with 194 
20.5% abundance, calling for caution when analyzing antisense transcription by novel high-195 
throughput technologies, and highlighting the necessity to validate data by alternative methods.   196 
 197 
Three additional technical aspects deserve comment. The use of the HIV-1 vector containing a 198 
GFP ORF in the place of env could disturb transcription and splicing.  The Northern blot in Figure 2B 199 
excludes significant defects in viral transcription and splicing. The integrity of transcription was 200 
further assessed by RT-qPCR using primers flanking the major introns of HIV to confirm the detection of 201 
multiply, singly and unspliced transcripts (data not shown).  We examined the degree of conservation 202 
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of the tag sequence to assess whether the tags displayed a perfectly matched sequence 203 
corresponding to the HIV-1 vector DNA. We tested 0, 1 and 2 mismatches to ensure that we 204 
would capture the putative error rate of the viral reverse transcriptase, as well as base miscalling 205 
of the SOLiD sequencing software. Upon HIV vector-specific tag analysis, 96.97% of the tags 206 
displayed a perfect match with the HIV vector genome, 2.92% presented one mismatch and only 207 
0.11% presented two mismatches. We also identified a limited number of reads (<0.01%) that 208 
mapped to the HIV-1 vector genome in the mock infected cells (Table 1). Upon inspection, all 209 
tags were HIV-specific, indicating a small level of contamination occurring through the 210 
experimental procedure (from culture to library preparation).  211 
  212 
The cellular transcriptome during infection. The high-throughput sequencing analysis of 213 
SAGE-RNA allowed the detection of 36,271 human expressed genes (79.8%), according to the 214 
RefSeq database (Table 1). On average, each transcript was represented by 815 tags (ranging 215 
from 0 to 3.8 millions, and with a median of 14.7). While the overall distribution in expression 216 
levels was not different for mock and HIV-1 infected cells (Figure 3), the identity of transcripts 217 
contained in mock or HIV-infected samples was significantly modified. Out of the detected 218 
transcripts, 826 (2.3%) were significantly differentially modulated between mock and HIV-219 
infected samples at a stringent adjusted P value of 10−4 at 24h post-infection. Ingenuity pathway 220 
analysis (www.ingenuity.com) identified “cellular growth and proliferation” and “RNA post-221 
transcriptional modification” as prominent modulated functions, including as relevant networks 222 
those related to cell cycle, DNA replication and repair, gene expression, and cell death. There 223 
was down regulation in HIV-infected cells of many of the genes associated to those networks, 224 
consistent with marked cellular compromise and stress. The complete set of differentially 225 
expressed genes is included in Supplemental File 3. Of notice, some of the differentially 226 
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expressed genes include non-protein coding transcripts such as spliceosomal and small nucleolar 227 
RNAs that are not generally thought of as polyadenylated, and should not have been captured by 228 
SAGE. However, there is increasing evidence that poly(A) tails can be added to such RNAs, 229 
possibly marking them for degradation (5, 25). 230 
 231 
We assessed the overlap between the set of genes that were identified as differentially expressed 232 
in the current study with those from various microarray studies in the literature that investigated 233 
differential expression in CD4+ T cells (42), CD8+ T cells (41), monocytes (17), and lymph 234 
nodes (29) during HIV-1 infection in vivo, as well as with a set of validated genes compiled by 235 
Giri et al. (16) from microarray studies published between 2000 and 2006. The overlap varied 236 
from 4% in the study of circulating monocytes in HIV-infected individuals (17) to 8% in the 237 
analysis of lymphatic tissue in the setting of various stages of HIV-1 infection in vivo (29). There 238 
was also a 6% overlap with a set of validated genes curated by Giri et al. (16). The final shortlist 239 
of 52 genes common between the present and one or more of the previous studies (Supplemental 240 
File 4) was also enriched for genes involved in cell cycle, DNA replication and repair, and cell 241 
proliferation. However, it should be underscored that differences in the nature of the techniques 242 
(deep-sequencing vs. microarray), a lack of recent studies using new generation microarrays for 243 
the transcriptome analysis of in vitro infection of T cell lines - the comparable experiment as the 244 
one completed herein, and general differences in study design makes comparison between studies 245 
of unclear significance. 246 
The approach also assessed whether HIV-1 infection modulates expression of repetitive elements 247 
or endogenous retroviruses. We observed very active transcription of these elements, with one 248 
transcript in 237 being of such origin, corresponding in average to 123,123 reads in mock 249 
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(0.40%) and 129,149 reads in HIV-1 (0.45%) mapping to the genomic Repbase repository 250 
(Figure 3). Of these, 4021 and 4451 average reads mapped to human endogenous retroviruses 251 
(HERV) in mock and in HIV-infected cells, respectively (Figure 3). The modest increase in 252 
HERV in the HIV-infected cell results mainly from the contribution of HERVK which increases 253 
from 3,331 to 3,814 average tags. The biological role of the prominent transcriptional activity of 254 
endogenous retroelements, i.e. regulatory activity or generation of translated products, needs 255 
further analysis (13).  256 
 257 
Conclusions. Analysis of deep sequence data using SAGE allowed the precise measurement of 258 
expression level of the proviral genome in HIV-1-infected cells and identified a small component 259 
of antisense viral transcription. Improvements in RNA-Seq will increasingly deliver information 260 
on both strand specificity and nature of the transcript, including splice forms, and sequence 261 
variation, that will facilitate the study of the dynamics of viral-host interactions (28). Extending 262 
this approach to replication-competent HIV-1 isolates, and to different cellular backgrounds, may 263 
reveal differences in viral-host interactions due to specific strain or cellular factors. 264 
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 472 
Figures 473 
 474 
Figure 1 - Overview of experimental and analytical procedures.  475 
Panel A, Experimental pipeline. Panel B, Bioinformatics pipeline.  476 
 477 
Figure 2 - Distribution of HIV-specific tags along the viral genome.  478 
(A) The HIV vector genome is depicted on the top panel with nucleotide positioning, NlaIII 479 
restriction sites (vertical black bars), the common sense transcription start site (TSS; red arrow) 480 
and the polyadenylation signal (poly(A); red vertical bar) are shown below. Multiple antisense 481 
transcription start sites (distributed between positions 9175 and 8714; only two are drawn here 482 
for figure simplicity; green arrows), and the poly(A) signal (vertical green bar), as described in 483 
Landry et al. (26), are indicated. HIV-1 open reading frames are also indicated, including the 484 
putative antisense protein (ASP). The bottom panel indicates the density of tags (vertical axis) 485 
distributed along the HIV-1 vector genome (x-axis), for both HIV-1 samples (HIV rep1 and HIV 486 
rep2) and mock samples (Mock rep1 and Mock rep2). The five major peaks are numbered at the 487 
bottom of the figure, displaying the number of tags at each peak, as well as the proportion of 488 
these tags representing sense or antisense transcription. (B) Total RNA from mock or HIV-based 489 
vector infected cells was extracted using miRvana or Trizol at 22h and 24h post-exposure and 490 
subjected to Northern blot hybridization. Left panel, total RNA gel electrophoresis. Right panels, 491 
Northern blots using strand-specific oligonucleotide probes aligning to the corresponding peak of 492 
tags detected by SAGE-Seq. Probes were designed to anneal with sense transcripts (red probes, 493 
top panels) or antisense transcripts (green probes, bottom panels), with nucleic acid sequence 494 
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complementary to the identified peak tag sequence. The plasmid encoding HIV vector genome 495 
digested with BglII and AflII was used as positive control for hybridization (+). 496 
 497 
 Figure 3 - Analysis of cellular transcripts in mock and HIV-infected cells.  498 
Average tag density analysis in mock (black lines) and HIV-1 (red lines) samples for total 499 
cellular transcripts (lines), repetitive elements (dashed lines) and HERV elements (dotted lines). 500 
The figure indicates that most cellular transcripts were detected with 1 to 1000 tags (log 0 to 3, 501 
average 2.9 log), across the complete transcriptome. Only a few transcripts were identified in 502 
larger numbers (e.g. above 10000, log 4). Lesser number of tags was observed for the expressed 503 
repetitive elements (average 2.3 log) including HERVs (average 1.9 log). Statistical differences 504 
between mock and HIV-1 distributions were assessed by Wilcoxon test. 505 
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 506 
Tables 507 
Table 1 - Mapping to the human genome, human transcriptome, and HIV-1 vector genome. 508 
  509 
 Human HIV-1 vector 
Sample Genome tagsa  Transcriptome 
tagsb  
HIV-specific 
tagsc  
GFP-specific 
tagsd  
Mock rep1 30,668,095 38,730,420  45 69 
Mock rep2 31,611,573 43,691,287 2,334 2,862 
HIV rep1 27,894,076 33,337,832 11,7391 13,5487 
HIV rep2 29,484,387 36,666,667 10,9122 12,6344 
 510 
aAlignment/mapping to GRCh37 allowed 1 mismatch (n=1), 1 hit (m=1), read length of 24 (rl=24). 511 
bAlignment/mapping to RefSeq allowed 1 mismatch (n=1), 10 multiple hits (m=10), read length of 24 (rl=24). 512 
 
cAligmnent/mapping to HIV NL4-3∆env/eGFP was performed allowing 2 mismatches (n=2) and 2 multiple hits 513 
(m=2), read length of 24 (rl=24). 514 
  515 
 516 
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 517 
Supplemental Material 518 
Supplemental File 1 – Completion of viral cycle in SupT1 cells. 519 
(A) SupT1 cells were highly susceptible to HIV-based vector infection (compared to CEM and 520 
Jurkat T cell lines). At 24h and 36h post-infection, 54% and 93% of cells were successfully 521 
transduced.  (B) To establish the optimal time point to capture the completion of the viral 522 
replication cycle, as reflected by particle release (measured by p24 ELISA in the supernatant), we 523 
performed a time course collecting materials every 2 hours. The plots represent here non-524 
cumulative estimates, i.e. de novo production, calculated by subtracting the measurement at a 525 
given time point by the prior measurement. Shown are the percentage of GFP+ cells and mean 526 
fluorescence intensity (MFI), representing the success of viral translation (green), which peaks at 527 
22 hours, and followed by the peak of extracellular p24 (red) at 24 hours expected 2-4 after the 528 
peak of translation.  529 
File format: pdf 530 
This file can be viewed with: Adobe Acrobat Reader 531 
 532 
Supplemental File 2 – Optimal mapping parameters for read analysis. 533 
Read length (rl), number of mismatches (n) and multiple hits allowed (m) were tested to 534 
maximize the number of tags mapping to HIV-1 while minimizing the number of tags spuriously 535 
mapping to both viral and host genome. Y-axis: reads mapping to HIV-1 vector genome; x-axis: 536 
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number of reads mapping to HIV-1 but not to human genome. Parameters rl, n, and m are 537 
indicated only for the best conditions. 538 
File format: pdf 539 
This file can be viewed with: Adobe Acrobat Reader 540 
 541 
Supplemental File 3 – Transcripts differentially expressed between mock and HIV-1 542 
infected cells. 543 
File format: xls 544 
This file can be viewed with: Microsoft Excel Viewer 545 
 546 
Supplemental File 4 – Transcripts identified by SAGE-Seq common to previous studies 547 
using microarray technology. 548 
File format: xls 549 
This file can be viewed with: Microsoft Excel Viewer 550 
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